Development of an affinity-enhanced clinical candidate TCR targeting NY-ESO-1 with optimal potency and high specificity
Ou, Yusheng, Liu, Ming, Zhan, Kai, Wu, Wanli, Huang, Jiao, Sun, Hanli, Zheng, Hongjun, Yu, Xiaohong, Gong, Haiping, Han, Zhaosheng, Chen, Aiyuan, Liao, Youping, Lin, Yanmei, Liu, Ge, Liu, Qiuping, Ma, Ruijuan, Mei, Yingyi, Tang, Xianqing, Weng, Zhiming, Wu, Jieyi, Ye, Yun, Zhang, Tingting, Chen, Jiehong, Chen, Lin, Ding, Qingfeng, Fan, Hui, Hu, Jiajia, Huang, Jinhua, Huang, Lihong, Li, Qiaowei, Li, Siyun, Liu, Min, Shi, Jia, Tan, Xiangpeng, Wang, Xiaoling, Ruirui Xiang, Qingjia Yan, Zhang, Jianbin, Zheng, Wenjing, Shi, Zhong
Published in bioRxiv (17.10.2022)
Published in bioRxiv (17.10.2022)
Get full text
Paper